Product Images Topiramate

This is a tabular presentation of the study results on the change in the average monthly migraine period rate from baseline to double-blind phase across different dosages of Topiramate and Placebo. The values are expressed in (+SE). There are significant differences between the placebo group and each of the Topiramate groups (doses 50 mg/day, 100mg/day, and 200 mg/day) as evidenced by the p values (<0.010, <0.001).*

Each tablet contains 50mg of Topiramate, USP. This medication is only available with a prescription, and comes with complete prescribing information. The tablets should be stored at a controlled room temperature and kept out of reach of children.*

This is a description of a medicine called Topiramate, USP, available in tablet form with 100 mg strength. It contains 60 tablets and should only be dispensed with a medication guide that is provided separately to each patient. The usual dosage information is provided in the package insert, and it should be stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F) to protect it from moisture. This medicine is produced by Cadila Healthcare Ltd. in India and distributed in the US by Zydus Pharmaceuticals USA Inc. located in Pennington, NJ 08534.*

Topiramate Tablets, USP, are a medication used to treat seizures and migraines. Each tablet contains 200mg of Topiramate, USP. The usual dosage is available on the package insert. They should be stored at room temperature, protected from moisture, and kept out of reach of children. A medication guide is available at the Zydus Pharmaceuticals website or by calling their customer service number. They are manufactured by Zydus Pharmaceuticals (USA).*